VCYT vs TWST โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
TWST Captures Institutional Edge (2โ2 Pillars ยท 5โ5 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Twist Bioscience Corporation Common Stock (TWST) driven by superior Momentum & Technical, Options & Structure while VCYT counters with relative strength in Valuation, Growth & Margin. Fundamentally, VCYT trades at 15.3x Forward P/E with 15.0% operating margin (+15.1% YoY revenue) versus TWST at N/M Forward P/E and -28.8% operating margin (+27.9% YoY). In options structure, VCYT sits in BREAKDOWN (47th %ile IV; Dealer Gamma Walls on Pro) against TWST sits in CONSOLIDATION (19th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | VCYT Revenue | TWST Revenue | VCYT Op. Margin | TWST Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $90M | $30M | -24.2% | -277.5% | VCYT |
| FY2019 | $120M | $50M | -12.6% | -200.1% | VCYT |
| FY2020 | $120M | $90M | -30.1% | -155.5% | VCYT |
| FY2021 | $220M | $130M | -37.3% | -115.4% | VCYT |
| FY2022 | $300M | $200M | -13.9% | -115.3% | VCYT |
| FY2023 | $360M | $250M | -23.8% | -88.6% | VCYT |
| FY2024 | $450M | $310M | 3.6% | -70.6% | VCYT |
| FY2025 | $520M | $380M | 11.2% | -36.2% | VCYT |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | VCYT | TWST | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $2.0B | $7.4B | Larger Scale | TWST |
| Trailing P/E Ratio Valuation | 15.8x | N/M | Lower Multiple | VCYT |
| Forward P/E Ratio Valuation | 15.3x | N/M | Lower Multiple | VCYT |
| Revenue Growth (YoY) Growth | +15.1% | +27.9% | Higher Growth | TWST |
| Operating Margin (TTM) Profitability | 15.0% | -28.8% | Higher Margin | VCYT |
| Net Profit Margin Profitability | 21.8% | -28.3% | Higher Margin | VCYT |
| Return on Equity (ROE) Capital Efficiency | 9.4% | -19.1% | Higher ROE | VCYT |
| 52-Week Range Position Momentum | 5% ($22โ$61) | 42% ($23โ$220) | Stronger Trend | TWST |
| Beta / 30D Volatility Risk Regime | 3.01ฮฒ ยท 199% Vol | 3.13ฮฒ ยท 126% Vol | Lower Realized Risk | TWST |
| Unified Institutional Score Composite Signal | 49.1 / 100 (HOLD) | 51.7 / 100 (HOLD) | Higher Composite | TWST |